Results 41 to 50 of about 2,084 (194)

Outcomes of Anterior Chamber, Sulcus, and Pars Plana Glaucoma Drainage Device Placement in Glaucoma Patients

Journal of Ophthalmology, Volume 2022, Issue 1, 2022., 2022
Purpose. To assess outcomes of anterior chamber (AC), sulcus, and pars plana (PP) glaucoma drainage device (GDD) placement in glaucoma patients. Patients and Methods. Retrospective evaluation of glaucoma patients who underwent GDD insertion in the AC, sulcus, or PP at Massachusetts Eye and Ear between November 2016 and May 2021.
Sandy Samuel, Enchi K. Chang, Sanchay Gupta, Marika Chachanidze, Cameron E. Neeson, John B. Miller, Ta Chen Chang, David A. Solá-Del Valle, Alessandro Meduri   +8 more
wiley   +1 more source

Endophthalmitis following combined cataract extraction and placement of an iStent trabecular bypass device

American Journal of Ophthalmology Case Reports, 2020
Purpose: To report a case of post-operative endophthalmitis following combined cataract extraction and minimally invasive glaucoma surgery with placement of the iStent drainage device.
Ariel Campos Chaves, Alexander J. Grosinger, Richard D. Ten Hulzen, Michael W. Stewart, Syril K. Dorairaj   +4 more
doaj   +1 more source

Standalone Implantation of 2–3 Trabecular Micro-Bypass Stents (iStent inject ± iStent) as an Alternative to Trabeculectomy for Moderate-to-Severe Glaucoma [PDF]

Ophthalmology and Therapy, 2021
This retrospective consecutive study compared standalone implantation of multiple (2-3) trabecular micro-bypass stents (iStent inject ± iStent) (Multi-Stent group) vs trabeculectomy + mitomycin C (Trab group) in moderate to severe open-angle glaucoma (OAG).Eligible patients underwent Multi-Stent or Trab surgery from 2018 to 2020 and had at least 3 ...
Ricardo Augusto Paletta Guedes, Daniela Marcelo Gravina, Vanessa Maria Paletta Guedes, Alfredo Chaoubah   +3 more
openaire   +2 more sources

Twelve-Month Outcomes of iStent Infinite in Severe Open-Angle Glaucoma Compared with iStent Inject W in Mild-to-Moderate Disease. [PDF]

J Clin Med
Background/Objectives: The efficacy of two-stent implantation with iStent inject W is well established for mild-to-moderate open-angle glaucoma (OAG), whereas evidence for three-stent implantation with iStent infinite in severe OAG remains limited. We compared 12-month outcomes of a severity-based surgical strategy, using two stents in mild-to-moderate
Han S, Kim SW.
europepmc   +4 more sources

Long-Term Endothelial Safety Profile With iStent Inject in Patients With Open-Angle Glaucoma [PDF]

, 2023
PURPOSE: To report 5-year postoperative safety data of iStent inject, including overall stability, endothelial cell density (ECD), and endothelial cell loss (ECL) in patients with mild-to-moderate primary open-angle glaucoma (POAG). DESIGN: 5-year follow-
L. Jay Katz, Sheybani, Arsham, Lass, Jonathan H, Beth Ann Benetz, Arsham Sheybani, Thomas W. Samuelson, Jonathan H. Lass, Usner, Dale, De Francesco, Ticiana, Katz, L Jay, Dale Usner, Ahmed, Iqbal Ike K, Iqbal Ike K. Ahmed, Benetz, Beth Ann, Ticiana De Francesco, Samuelson, Thomas W   +15 more
core   +1 more source

iStent inject® and cataract surgery for mild-to-moderate primary open angle glaucoma in Japan: a cost-utility analysis [PDF]

International Journal of Ophthalmology, 2022
AIM: To evaluate the cost-utility of iStent inject® with cataract surgery vs cataract surgery alone in patients with mild-to-moderate primary open angle glaucoma (POAG) in the Japanese setting from a public payer's perspective.
Ataru Igarashi, Kyoko Ishida, Nobuyuki Shoji, Alice Chu, Heather Falvey, Ru Han, Maki Ueyama, Yoshie Onishi   +7 more
doaj   +1 more source

Two-Year Comparative Outcomes of First- and Second-Generation Trabecular Micro-Bypass Stents with Cataract Surgery

Clinical Ophthalmology, 2021
Ricardo Augusto Paletta Guedes,1 Daniela Marcelo Gravina,1 Vanessa Maria Paletta Guedes,1 Alfredo Chaoubah2 1Glaucoma Department, Paletta Guedes Eye Institute, Juiz de Fora, MG, Brazil; 2Statistics Department, Federal University of Juiz De Fora, Juiz de ...
Paletta Guedes RA, Gravina DM, Paletta Guedes VM, Chaoubah A   +3 more
doaj  

Use of iStent as a Standalone Operation in Patients with Open-Angle Glaucoma

Journal of Ophthalmology, 2020
Purpose. The iStent provides a direct pathway for aqueous outflow from the anterior chamber to Schlemm’s canal in patients with open-angle glaucoma (OAG).
Yu-Yen Chen, Yun-Ju Lai, Yung-Feng Yen, Li-Ying Huang   +3 more
doaj   +1 more source

iStent: Trabecular Micro-Bypass Stent [PDF]

, 2020
AbstractWithin the class of procedures termed minimally invasive glaucoma surgery (MIGS), the iStent Trabecular Micro-Bypass Stent (Glaukos Corporation, San Clemente, CA, USA) is an intraocular implant that resides within Schlemm’s canal and allows for direct bypass of the trabecular meshwork by aqueous fluid.
Christine L. Larsen, Thomas W. Samuelson
openaire   +1 more source

Resultados longitudinais comparativos de mundo real do iStent inject® versus iStent inject® W no glaucoma de ângulo aberto [PDF]

Revista Brasileira de Oftalmologia
RESUMO Objetivo: Comparar a eficácia e a segurança do iStent inject® e do iStent inject® W em pacientes com glaucoma primário de ângulo aberto submetidos a implante isolado ou combinado com facoemulsificação. Métodos: Estudo retrospectivo, longitudinal,
Daniel Augusto Guedes Moraes, Ricardo Augusto Paletta Guedes, Daniela Marcelo Gravina, Laura Assis de Castro Paletta, Vanessa Maria Paletta Guedes, Alfredo Chaoubah   +5 more
doaj   +2 more sources